The German big pharma will submit a new drug application to the US FDA after success at phase 3 for nerandomilast.

Boehringer Ingelheim said that it will submit a new drug application for nerandomilast based on the positive results.

The Food and Drug Administration (FDA) has cleared an investigational new drug application for the novel treatment, APTN-101, ...

On Friday, the U.S. Food and Drug Administration approved Eli Lilly's eczema drug ... The FDA's approval is a "big win for ...

The number of lives lost around the world due to infections that are resistant to the medications intended to treat them ...

PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, today announced an update for its New Drug Application for Ketamine from the U.

Researchers have unveiled a new form of light that promises to revolutionize how we see the world at its tiniest level.

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today a ...

Newcells Biotech (“Newcells”), a leading drug discovery partner specialising in the development of in vitro models and ...

New Delhi: Indian public health campaigners on Wednesday said they will oppose the patent applications of a promising new but ...

NYU study reveals 86% of drug researchers have used substances, sparking debate over its impact on scientific objectivity.

Japan's health ministry has accepted for review a new drug application (NDA) for GSK's Blenrep blood cancer treatment, marking the third major regulatory filing acceptance for the drug.